Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Patricia Zuno-Mitchell"'
Autor:
Christopher Kirk, Yu Qian, Jinhai Wang, Patricia Zuno-Mitchell, David L Bade, Neel K Anand, Cristina Delgado Martin, Vaishnavi Beena Valsan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/98101afd8e864a8c8b7ae7a90c80686c
Autor:
Sean M. Carroll, Xiaomu Chen, Alexander Scholz, Norman M. Greenberg, May Sumi, Patricia Zuno-Mitchell, Kevin S. Williamson, Daniel Emerling, Gilson Baia, Felix Chu, David R. Minor, Jacob Glanville, Beatriz Millare, Jeremy Sokolove, Xiaobin Tang, Yann Chong Tan, Wayne Volkmuth, Amy Manning-Bog, Lawrence Steinman, Guy Cavet, Ngan Nguyen, Shuwei Jiang, Tito Serafini, Michael G Harbell, Dongkyoon Kim, Eldar Giladi, Danhui Zhang, Jeff DeFalco, William H. Robinson, Yvonne Leung, Gregg Espiritu Santo, Christine Dowd, Nicole Haaser
Publikováno v:
Clinical Immunology. 187:37-45
There is significant debate regarding whether B cells and their antibodies contribute to effective anti-cancer immune responses. Here we show that patients with metastatic but non-progressing melanoma, lung adenocarcinoma, or renal cell carcinoma exh
Autor:
William H. Robinson, Daniel Emerling, May Sumi, Felix Chu, Norman M. Greenberg, Gilson Baia, Wayne Volkmuth, Patricia Zuno-Mitchell, Danhui Zhang, Judevin Lugar Sapugay, Amy Manning-Bog, Beatriz Millare, Michael G Harbell, Iraz T Aydin, Sheila Fernandez, Alexander Scholz, Ngan Nguyen, Nicole Haaser, Jeff DeFalco, Jonathan Benjamin
Publikováno v:
Journal of Clinical Oncology. 36:e15015-e15015
e15015Background: It is unclear exactly how B cells and their antibodies (Abs) influence the anti-cancer immune response. We've proposed that anti-tumor Abs drive or amplify anti-tumor immune effec...
Publikováno v:
The Journal of Infectious Diseases. 193:821-828
Background. A quadrivalent meningococcal conjugate vaccine (MCV-4) is recommended for United States teenagers. The duration of protective immunity is unknown. We investigated serum antibody persistence 3 years after vaccination of adolescents. Method
Publikováno v:
Infection and Immunity. 70:6021-6031
The capsular polysaccharide ofNeisseria meningitidisgroup B is an autoantigen, whereas noncapsular antigens are highly variable. These factors present formidable challenges for development of a broadly protective and safe group B vaccine. Mice and gu
Publikováno v:
Infection and Immunity. 69:3762-3771
Neisserial surface protein A (NspA) is currently being investigated with humans as a candidate vaccine for the prevention of meningococcal disease. Although NspA is highly conserved, the ability of anti-NspA antibodies to bind to or elicit complement
Autor:
Patricia Zuno-Mitchell, Rino Rappuoli, Laura Santini, Luisa Lozzi, Paolo Neri, Francesca Piccinetti, Brunella Brunelli, Gregory R. Moe, Sharon S. Lee, Marzia Monica Giuliani, Dan M. Granoff, Luisa Bracci, Jeannette Adu-Bobie
Publikováno v:
Università degli Studi di Siena-IRIS
Molecular mimetic Ags are of considerable interest as vaccine candidates. Yet there are few examples of mimetic Ags that elicit protective Ab against a pathogen, and the functional activity of anti-mimetic Abs has not been studied in detail. As part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daae3d310d5284484c0ec18f9f0b3b2a
https://usiena-air.unisi.it/handle/11365/37472
https://usiena-air.unisi.it/handle/11365/37472